The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Natural Products for the Treatment of Autoimmune Arthritis: Their Mechanisms of Action, Targeted Delivery, and Interplay with the Host Microbiome
Open accessAbstract
Rheumatoid arthritis (RA) is a chronic, debilitating illness characterized by painful swelling of the joints, inflammation of the synovial lining of the joints, and damage to cartilage and bone. Several anti-inflammatory and disease-modifying drugs are available for RA therapy. However, the prolonged use of these drugs is associated with severe side effects. Furthermore, these drugs are effective only in a proportion of RA patients. Hence, there is a need to search for new therapeutic agents that are effective yet safe. Interestingly, a variety of herbs and other natural products offer a vast resource for such anti-arthritic agents. We discuss here the basic features of RA pathogenesis; the commonly used animal models of RA; the mainstream drugs used for RA; the use of well-characterized natural products possessing anti-arthritic activity; the application of nanoparticles for efficient delivery of such products; and the interplay between dietary products and the host microbiome for maintenance of health and disease induction. We believe that with several advances in the past decade in the characterization and functional studies of natural products, the stage is set for widespread clinical testing and/or use of these products for the treatment of RA and other diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Pathogenesis of Rheumatoid Arthritis
McInnes, I. B., & Schett, G. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1004965 · Cited by 5,514
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839 · cited 1×
“Liposomes can encapsulate both hydrophobic and hydrophilic drugs and can release the entrapped drug at designated targets [182,183].”
BackgroundEkor, M. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00177 · Cited by 3,919
Nanoemulsion: Concepts, development and applications in drug delivery
Singh, Y., Meher, J. G., Raval, K., Khan, F. A., Chaurasia, M., Jain, N. K., & Chourasia, M. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.008 · Cited by 1,358 · cited 1×
“Nanoemulsions result from the dispersion of two immiscible liquids, typically water and oil, and are stabilized using an appropriate surfactant [187].”
BackgroundAnselmo, A. C., & Mitragotri, S. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10003 · Cited by 1,321
An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis
Chen, J., Wright, K., Davis, J. M., Jeraldo, P., Marietta, E. V., Murray, J., Nelson, H., Matteson, E. L., & Taneja, V. (2016) · Genome Medicine · doi:10.1186/s13073-016-0299-7 · Cited by 858
Understanding the role of gut microbiome–host metabolic signal disruption in health and disease
Holmes, E., Li, J. V., Athanasiou, T., Ashrafian, H., & Nicholson, J. K. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.05.006 · Cited by 541
HENCH, P. S. (1950) · Archives of Internal Medicine · doi:10.1001/archinte.1950.00230100002001 · Cited by 501
Regulation of Inflammation by Adenosine
Haskó, G., & Cronstein, B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00085 · Cited by 367
Nanomicellar formulations for sustained drug delivery: strategies and underlying principles
Trivedi, R., & Kompella, U. B. (2010) · Nanomedicine · doi:10.2217/nnm.10.10 · Cited by 358 · cited 1×
“The surface of the nanomicelles is suitable for conjugation with cell/tissue-targeting ligands [188,189].”
BackgroundImpacts of microbiome metabolites on immune regulation and autoimmunity
Haase, S., Haghikia, A., Wilck, N., Müller, D. N., & Linker, R. A. (2018) · Immunology · doi:10.1111/imm.12933 · Cited by 239 · cited 2×
“In addition to propionate and acetate, these essential short-chain fatty acids (SCFAs) affect host cells by inhibiting histone-deacetylase to promote anti-inflammatory responses [198].”
BackgroundThe dual role of short fatty acid chains in the pathogenesis of autoimmune disease models
Mizuno, M., Noto, D., Kaga, N., Chiba, A., & Miyake, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173032 · Cited by 230
A systematic review on the Rosa canina effect and efficacy profiles
Chrubasik, C., Roufogalis, B. D., Müller‐Ladner, U., & Chrubasik, S. (2008) · Phytotherapy Research · doi:10.1002/ptr.2400 · Cited by 220
Risk of liver disease in methotrexate treated patients
Conway, R., & Carey, J. J. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i26.1092 · Cited by 170
Min, S.-Y., Yan, M., Kim, S. B., Ravikumar, S., Kwon, S.-R., Vanarsa, K., Kim, H.-Y., Davis, L. S., & Mohan, C. (2015) · Journal of Inflammation · doi:10.1186/s12950-015-0097-9 · Cited by 87
The Gut Microbiome, Energy Homeostasis, and Implications for Hypertension
Riedl, R. A., Atkinson, S. N., Burnett, C. M. L., Grobe, J. L., & Kirby, J. R. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0721-6 · Cited by 58
Cited by
Immunomodulators Inspired by Nature: A Review on Curcumin and Echinacea
Catanzaro, M., Corsini, E., Rosini, M., Racchi, M., & Lanni, C. (2018) · Molecules · doi:10.3390/molecules23112778 · Cited by 258
Metadata
- Authors
- Dudics, S., Langan, D., Meka, R. R., Venkatesha, S. H., Berman, B. M., Che, C.-T., & Moudgil, K. D.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-08-24
- Volume
- 19
- Issue
- 9
- Pages
- 2508
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2888413512
- Cited by
- 162
- References
- 16
- FWCI
- 19.47
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.